Tistoryview
Disease&Treatment/Cornea&Ocular surfaces
Anti-inflammatory treatment for dry eye syndrome, Cyclosporine A series eye drops, action principle and domestically available products
eye_doc 2025. 4. 21. 17:03๐ Cyclosporine Eye Drops for Dry Eye – A Shift Toward Anti-inflammatory Treatment
Dry eye disease is now considered a chronic inflammatory condition,
not merely a tear deficiency. Cyclosporine A (CsA), an immunomodulatory agent,
has emerged as a frontline treatment by suppressing T-cell activity and restoring tear film integrity.
โ How It Works
- Hyperosmolar tears activate antigen-presenting cells → T-cells → cytokine cascade
- CsA suppresses this by:
- Inhibiting T-cell activation
- Reducing proinflammatory cytokines
- Preserving goblet cells and lacrimal glands
โ Key Product Forms
FormNotes
Emulsion | Requires shaking; ex: Restasis, Iporin |
Nano-emulsion | No shaking; better absorption; ex: Cyporin-N, Clesier |
High-concentration | 0.1% formulation, once-daily; ex: Santen’s Ikervis (coming soon) |
โ Benefits of Cyclosporine
- Long-term safety established
- Reduces inflammation on ocular surface
- Improves tear production and goblet cell density
- Used for moderate to severe dry eye and post-surgical inflammation
โ Popular Brands in Korea
CategoryExamples
Brand name | Restasis |
Nano-form | Cyporin-N, Clesier, Tisporin |
Generics | Iporin, Retas, Anaforin, etc. |